Updates on Anticoagulant

A combination of reflux due to valvular incompetence, and venous hypertension due to thrombotic obstruction, is thought to contribute to post-thrombotic syndrom

The presence of factor V Leiden or prothrombin gene mutation is reportedly an independent predictor of a higher risk of PTS

The incidence of rate VTE is high in individuals with cancer of

A recent guideline for antithrombotic therapy does not recommend routine use of ECSs to prevent PTS in patients with acute DVT

Which of the following factors are found to be significant predictors for the development of VTE

Among patient with venous leg ulcers, the use of Intermittent Pneumatic Compression with standard wound care was reported significantly promoted wound healing

Which of the chemotherapeutic agent is not associated with increased risk of venous and arterial thrombosis

Available evidence suggests that exercise training may improve PTS symptoms

Enoxaparin is the recommended thromboprophylactic regimens in cancer patients

The use of DOAC is FDA approved for DVT prophylaxis in acute medically ill patients?

If the cancer is resolve ,it is recommended to continue anticoagulant as patient has history of thrombosis

What is the studied dose of DOAC in DVT prophylaxis in acute medically ill patients:

The initial heparin dose in the non-obese 16 units/kg/h and 12 units/kg/h in the obese and morbidly obese are associated with similar time to first therapeutic aPTT

what are the benefits of using DOAC in DVT prophylaxis in acute medically ill patients :

Based on the available clinical data and pharmacokinetic properties of Rivaroxaban , no dose adjustments are required with regard to the patient’s body we

The extended duration of RIvaroxaban was safe and effective when compared with 10 days enoxaparin .

Dabigatran may be considered in obese patients

Clinical scores, in combination with patient clinical examination and laboratory tests improve:

Apixaban has the best evidence for utilization of DOACs in obese patients.

Before the score is used in clinical practice the predictive ability of the model should be evaluated. the model is validated internally or externally

According to the CDC, the number of elder person that got VTE is 1 to 1000 person

Which model implies ascribing groups of patients to broad risk categories or “buckets” of risk without going through individualized point scoring

The use of anticoagulant increased in Artrial fibrillation patient in order to reduces the risk of ischemic stroke

Khorana risk score is validated to assess the risk of VTE in cancer patients starting chemotherapy

Dabigatran can help reduce the risk of stroke in AFib not caused by a heart valve problem

According to chest guide line DOAC are preferred than warfarin on treatment of VTE

The utility of the NOACs for VTE treatment in vulnerable patients, such as those who are morbidly obese is clear now and established by new studies